Walleye Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.79M Buy
7,681
+7,593
+8,628% +$1.76M ﹤0.01% 2933
2026
Q2
$18.7K Sell
88
-2,130
-96% -$418K ﹤0.01% 4400
2026
Q1
$435K Sell
2,218
-13,861
-86% -$2.69M ﹤0.01% 2772
2025
Q4
$2.79M Buy
16,079
+16,001
+20,514% +$2.91M 0.01% 1592
2025
Q3
$14.9K Sell
78
-130
-63% -$23.1K ﹤0.01% 4240
2025
Q2
$37.4K Sell
208
-133
-39% -$23.1K ﹤0.01% 4120
2025
Q1
$57.7K Sell
341
-3,399
-91% -$558K ﹤0.01% 3805
2024
Q4
$564K Buy
3,740
+1,479
+65% +$230K ﹤0.01% 2887
2024
Q3
$351K Sell
2,261
-14,708
-87% -$2.2M ﹤0.01% 3605
2024
Q2
$2.32M Buy
16,969
+10,423
+159% +$1.43M ﹤0.01% 1964
2024
Q1
$871K Buy
+6,546
New +$849K ﹤0.01% 2724
2019
Q4
– Sell
-260
Closed -$28K – 1889
2019
Q3
$28K Hold
260
– – ﹤0.01% 1695
2019
Q2
$26K Buy
+260
New +$25K ﹤0.01% 1491

Other funds holding DGX

Walleye Capital's DGX Position: Q3 2026 in Review

Walleye Capital increased its Quest Diagnostics (DGX) stake by 8,628% in Q3 2026, buying an estimated $1.76M and bringing the position to 7,681 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Walleye Capital first reported a position in DGX in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.79M in Q4 2025. 1,134 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Walleye Capital held 7,681 shares of Quest Diagnostics worth $1.79M as of Q3 2026.
  • Walleye Capital bought 7,593 Quest Diagnostics shares in Q3 2026, an estimated $1.76M.
  • Quest Diagnostics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2933 holding.
  • Walleye Capital first reported a position in Quest Diagnostics in Q2 2019 and has held it in 13 quarters since.
  • Walleye Capital's Quest Diagnostics position peaked at $2.79M in Q4 2025.
  • 1,134 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.